Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gerald Buchert

Physician Assistant, Surgical Bellaire, TX Physician Assistant

NPI 1023049277 CMS profile 11056981

5420 West Loop S Ste 2100, Bellaire, TX 77401

Open in the dashboard

General payments

$148,029

294 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gerald Buchert of Bellaire, TX is reported in the CMS Open Payments database as having received $148,029 across 294 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $38,443 83
2024 General $31,801 75
2023 General $23,124 51
2022 General $20,278 34
2021 General $34,383 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gerald Buchert
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Gerald Buchert were reported at $38,443. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Gerald Buchert Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $34,383 $111 $36–$285 $132
2022 $20,278 $126 $44–$350 $149
2023 $23,124 $137 $47–$355 $160
2024 $31,801 $146 $49–$384 $164
2025 $38,443 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $114,201 213 payments
  2. Ethicon US, LLC $32,876 59 payments
  3. DePuy Synthes Sales Inc. $545 11 payments
  4. Ethicon Inc. $165 1 payment
  5. Amgen Inc. $124 1 payment
  6. Ossur Americas., Inc $74 7 payments
  7. Pacira Pharmaceuticals Incorporated $31 1 payment
  8. AbbVie, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $128,698 122 payments
  2. Travel and Lodging $14,144 62 payments
  3. Food and Beverage $5,037 108 payments
  4. Education $150 2 payments
Products named General payments · program years 2021–2025
  1. STRATAFIX $143,905 242 payments
  2. MONOCRYL $125,786 159 payments
  3. DERMABOND $78,869 104 payments
  4. PDS $71,796 91 payments
  5. DERMABOND PRINEO $54,448 76 payments
  6. EVARREST $1,194 7 payments
  7. SURGIFLO Hemostatic Matrix $281 8 payments
  8. Teligen $201 4 payments
  9. VIPER $172 3 payments
  10. EXPEDIUM $165 3 payments
  11. Other $853 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

592

Median for Physician Assistant: 241

Drug cost

$3,827

Median for Physician Assistant: $4,110

Branded share of claims

5.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 182 $1,918
Meloxicam Generic 224 $597
Methocarbamol Generic 75 $543
Acetaminophen-Codeine Acetaminophen With Codeine Brand 35 $345
Tizanidine Hcl Generic 24 $148
Tramadol Hcl Generic 33 $148
Methylprednisolone Generic 19 $127

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$33,083

Medicare's payments for the services billed

Medicare patients

204

Average age 74

Services billed

586

113 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 37%
Osteoporosis 33%
Diabetes 26%
Depression 21%
Chronic kidney disease 20%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

294 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record